BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38758417)

  • 1. Development of EBV Related Diffuse Large B-cell Lymphoma in Deficiency of Adenosine Deaminase 2 with Uncontrolled EBV Infection.
    Gardner LS; Vaughan L; Avery DT; Meyts I; Ma CS; Tangye SG; Varikatt W; Lin MW
    J Clin Immunol; 2024 May; 44(5):118. PubMed ID: 38758417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADA2 deficiency complicated by EBV-driven lymphoproliferative disease.
    Staples E; Simeoni I; Stephens JC; Allen HL; ; Wright P; Davies EG; Javid B; Gkrania-Klotsas E; Gattens M; Firth H; Shamardina O; Deevi SVV; Prapa M; Uttenthal B; Kumararatne D; Thaventhiran JED
    Clin Immunol; 2020 Jun; 215():108443. PubMed ID: 32353633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus latency patterns in polymorphic lymphoproliferative disorders and lymphomas in immunodeficiency settings: Diagnostic implications.
    Volaric AK; Saleem A; Younes SF; Zhao S; Natkunam Y
    Ann Diagn Pathol; 2024 Jun; 70():152286. PubMed ID: 38447253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late-Onset EBV Susceptibility and Refractory Pure Red Cell Aplasia Revealing DADA2.
    Le Voyer T; Boutboul D; Ledoux-Pilon A; de Fontbrune FS; Boursier G; Latour S; Le Guenno G
    J Clin Immunol; 2020 Aug; 40(6):948-953. PubMed ID: 32643137
    [No Abstract]   [Full Text] [Related]  

  • 5. Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
    Uccini S; Al-Jadiry MF; Scarpino S; Ferraro D; Alsaadawi AR; Al-Darraji AF; Moleti ML; Testi AM; Al-Hadad SA; Ruco L
    Hum Pathol; 2015 May; 46(5):716-24. PubMed ID: 25704629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus (EBV)-induced B-cell proliferative disorder after chemotherapy in a patient with hemophagocytic lymphohistiocytosis with associated EBV-induced T-cell proliferation.
    Suzumiya J; Ohshima K; Kanda M; Kumagawa M; Nagano M; Hirata M; Nawa Y; Tamura K; Kikuchi M
    Leuk Lymphoma; 2000 May; 37(5-6):593-604. PubMed ID: 11042520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testicular ischemia in deficiency of adenosine deaminase 2 (DADA2).
    Clarke K; Campbell C; Omoyinmi E; Hong Y; Al Obaidi M; Sebire N; Brogan PA
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):39. PubMed ID: 31291964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detailed analysis of Japanese patients with adenosine deaminase 2 deficiency reveals characteristic elevation of type II interferon signature and STAT1 hyperactivation.
    Nihira H; Izawa K; Ito M; Umebayashi H; Okano T; Kajikawa S; Nanishi E; Keino D; Murakami K; Isa-Nishitani M; Shiba T; Honda Y; Hijikata A; Yasu T; Kubota T; Hasegawa Y; Kawashima Y; Nakano N; Takada H; Ohga S; Heike T; Takita J; Ohara O; Takei S; Takahashi M; Kanegane H; Morio T; Iwaki-Egawa S; Sasahara Y; Nishikomori R; Yasumi T
    J Allergy Clin Immunol; 2021 Aug; 148(2):550-562. PubMed ID: 33529688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncontrolled Epstein-Barr Virus as an Atypical Presentation of Deficiency in ADA2 (DADA2).
    Brooks JP; Rice AJ; Ji W; Lanahan SM; Konstantino M; Dara J; Hershfield MS; Cruickshank A; Dokmeci E; Lakhani S; Lucas CL
    J Clin Immunol; 2021 Apr; 41(3):680-683. PubMed ID: 33394316
    [No Abstract]   [Full Text] [Related]  

  • 10. Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma.
    Tisi MC; Cupelli E; Santangelo R; Maiolo E; Alma E; Giachelia M; Martini M; Bellesi S; D'Alò F; Voso MT; Pompili M; Leone G; Larocca LM; Hohaus S
    Leuk Lymphoma; 2016; 57(3):628-34. PubMed ID: 26458141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma arising in patient with a history of EBV-positive mucocutaneous ulcer and EBV-positive nodal polymorphous B-lymphoproliferative disorder.
    Daroontum T; Kohno K; Inaguma Y; Okamoto A; Okamoto M; Kimura Y; Nagahama M; Sakakibara A; Satou A; Nakamura S
    Pathol Int; 2019 Jan; 69(1):37-41. PubMed ID: 30450620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis.
    Zhao CX; Yan ZX; Wen JJ; Fu D; Xu PP; Wang L; Cheng S; Hu JD; Zhao WL
    Mol Cancer; 2021 Dec; 20(1):153. PubMed ID: 34852843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).
    Lee PY; Kellner ES; Huang Y; Furutani E; Huang Z; Bainter W; Alosaimi MF; Stafstrom K; Platt CD; Stauber T; Raz S; Tirosh I; Weiss A; Jordan MB; Krupski C; Eleftheriou D; Brogan P; Sobh A; Baz Z; Lefranc G; Irani C; Kilic SS; El-Owaidy R; Lokeshwar MR; Pimpale P; Khubchandani R; Chambers EP; Chou J; Geha RS; Nigrovic PA; Zhou Q
    J Allergy Clin Immunol; 2020 Jun; 145(6):1664-1672.e10. PubMed ID: 31945408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
    Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
    J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary hepatic lymphoma as other iatrogenic immunodeficiency-related lymphoproliferative disorders: a case report and review of the literature.
    Tsuji H; Yoshifuji H; Shindo T; Hishizawa M; Ishida A; Fujimoto M; Kitagori K; Akizuki S; Murakami K; Nakashima R; Hashimoto M; Tanaka M; Ohmura K
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):172-177. PubMed ID: 32985951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBV-positive Reactive Hyperplasia Progressed into EBV-positive Diffuse Large B-cell Lymphoma of the Elderly over a 6-year Period.
    Kunitomi A; Hasegawa Y; Asano N; Kato S; Tokunaga T; Miyata Y; Iida H; Nagai H
    Intern Med; 2018 May; 57(9):1287-1290. PubMed ID: 29279478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nodal EBV-positive polymorphic B cell lymphoproliferative disorder with plasma cell differentiation: clinicopathological analysis of five cases.
    Satou A; Tabata T; Suzuki Y; Sato Y; Tahara I; Mochizuki K; Oishi N; Takahara T; Yoshino T; Tsuzuki T; Nakamura S
    Virchows Arch; 2021 May; 478(5):969-976. PubMed ID: 33169195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic Defects in B Cell Development and Differentiation, T Cell Exhaustion and Altered Unconventional T Cell Generation Characterize Human Adenosine Deaminase Type 2 Deficiency.
    Yap JY; Moens L; Lin MW; Kane A; Kelleher A; Toong C; Wu KHC; Sewell WA; Phan TG; Hollway GE; Enthoven K; Gray PE; Casas-Martin J; Wouters C; De Somer L; Hershfield M; Bucciol G; Delafontaine S; Ma CS; Tangye SG; Meyts I
    J Clin Immunol; 2021 Nov; 41(8):1915-1935. PubMed ID: 34657246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoproliferative disorders with concurrent HHV8 and EBV infection: beyond primary effusion lymphoma and germinotropic lymphoproliferative disorder.
    Wang W; Kanagal-Shamanna R; Medeiros LJ
    Histopathology; 2018 Apr; 72(5):855-861. PubMed ID: 29105119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary Epstein-Barr virus associated lymphoproliferative disorder developing in a patient with angioimmunoblastic T cell lymphoma on vorinostat.
    Smeltzer JP; Viswanatha DS; Habermann TM; Patnaik MM
    Am J Hematol; 2012 Sep; 87(9):927-8. PubMed ID: 22718468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.